If the corona virus epidemic has hit global economies, it is now bringing money to the same corona and pharma companies. American Multinational Pharmaceutical ..
If the corona virus epidemic has hit global economies, it is now bringing money to the same corona and pharma companies. Pfizer, the American multinational pharmaceutical corporation, reports how much we earn by selling the Kovid vaccine. The company hopes that the coronavirus vaccine brought by Pfizer to eradicate the corona virus will generate millions of sales worldwide. The company estimates that sales of the Kovid-19 vaccine, jointly developed by Pfizer and BioNTech, could reach $ 15 billion (approximately Rs 110 crore) by 2021.
In addition, contracts for the supply of more vaccines are likely to be signed in the coming days, rather than the order in hand. Pfizer said that if the signatures were made in this direction, the revenue would be even higher. The company expects Pfizer sales to be between $ 59.4 billion and $ 61.4 billion by 2021. Pfizer said a quarter of the company’s total sales are likely to come from sales of the Kovid-19 vaccine. Pfizer predicts that with people around the world roasting corona vaccination this year, their company sales will be solid.
Pfizer says people around the world are taking corona vaccines to revive macroeconomic and health care activities. If so, Pfizer reported fourth-quarter net income of $ 594 million in the wake of corona vaccination. The previous year it was $ 337 million. Pfizer reported $ 9.6 billion in profits in 2020.
It is learned that the corona vaccine made by Pfizer started getting approval from the concerned authorities at the end of last year. As a result, Pfizer said, more orders could come in this year and the vaccine could supply up to 2 billion doses. Pfizer is one of the largest pharmaceutical companies in the world. Pfizer, ranked 2020 Fortune 500, is the largest U.S. Ranked 64th on the list of corporations.